JWH-015

JWH-015 is a synthetic cannabinoid that acts as a selective agonist for the cannabinoid receptors. It is part of the naphthoylindole family of compounds and is known for its potential therapeutic applications as well as its use in scientific research.
Chemical Properties[edit]
JWH-015 is chemically classified as a naphthoylindole, with the full chemical name (2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone. It has a molecular formula of C24H23NO and a molecular weight of 341.45 g/mol. The compound is characterized by its indole core structure, which is common among many synthetic cannabinoids.
Pharmacology[edit]
JWH-015 acts as a selective agonist for the CB2 receptor, with a moderate affinity for the CB1 receptor. This selectivity makes it of interest for research into the endocannabinoid system and its potential therapeutic applications, particularly in the modulation of immune responses and inflammation.
Mechanism of Action[edit]
The primary action of JWH-015 is through its interaction with the CB2 receptor, which is predominantly expressed in the immune system. Activation of this receptor by JWH-015 can lead to anti-inflammatory effects and modulation of immune cell activity. The compound's lower affinity for the CB1 receptor, which is primarily found in the central nervous system, results in fewer psychoactive effects compared to other cannabinoids.
Potential Applications[edit]
Research into JWH-015 has explored its potential use in treating conditions such as chronic pain, inflammation, and autoimmune diseases. Its selective action on the CB2 receptor makes it a candidate for therapies that aim to minimize psychoactive side effects while providing therapeutic benefits.
Legal Status[edit]
The legal status of JWH-015 varies by country. In some jurisdictions, it is classified as a controlled substance due to its structural similarity to other synthetic cannabinoids that have been associated with recreational use and potential abuse.
Safety and Toxicology[edit]
As with many synthetic cannabinoids, the safety profile of JWH-015 is not fully understood. Studies have indicated that it may have a lower risk of psychoactive effects compared to other cannabinoids, but its long-term effects and potential toxicity remain areas of active research.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian